Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
has anyone tried contacting the company to see what the plans are?
Simply someone got impatience...
some action around here... what's up!
Due to the session timeout, thanks.
http://sunbiz.org/scripts/cordet.exe?action=DETFIL&inq_doc_number=L02000011371&inq_came_from=NAMFWD&cor_web_names_seq_number=0000&names_name_ind=N&names_cor_number=&names_name_seq=&names_name_ind=&names_comp_name=KIRKPHARMA&names_filing_type=
First document below "Document images".
Hi Vigo, I just wanted to point out that the link on your post is no longer active.
lol, be patient!
Thanks buddy! Long & strong here...
Wow! Great post.
Thanks bro! SYVC is a sleeping giant...
Fantastic work Vigo, thnx bro!!:) got ya marked now....
DD compilation --> ** All in one **
(updated 08/28/2011)
A/S 50 mln...reinstatement done:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62790092
SOS NEVADA update, RAM NIMMAGUDDA new secretary & treasurer:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66316125
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66316181
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66316584
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66319414
Must read, an old news about Maneesh - Synovics:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63486865
Possible RM with Maneesh Pharmaceutical:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63477280
About VINAY SAPTE:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65537682
VINAY SAPTE e-mail address on the SOS Florida:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66185562
About Maneesh Pharmaceuticals:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62698317
About SYNOVICS PHARMACEUTICALS INC:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62698630
Maneesh & USA export:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62713578
Last 10Q keys:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=62818153
Last interim CEO, Gerald Price:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63014687
SAPTE & his ownership in Maneesh:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63477893
Possible developments:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63486879
(to be continued)
....
Agree..!
Starting to get interesting.
... well not any more .. but it was nice.. hehe now it's printing 0.045
The ASK is printing 5 dollars on I-Hub... hahaha... Imagine
Things are going so nicely...
I doubt we'll see a filing before September/October. We'll see anyways... I am hoping things get delayed for a bit. Looking for some money! What does your gutt feeling tell ya'?
He's the same person, look @ his address on SOS Nevada and the address on the employment agreement with Spherix:
RAM NIMMAGUDDA
303 NORTH ROAD
City: CHESTER State: NJ
Zip Code: 07930 Country: USA
Status: Active
http://www.spherix.com/pdf/sec/8-k_08-31-09.pdf (page 8)
"If to the Executive:
Ram Nimmagudda, Ph.D.
303 North Road
Chester, NJ 07930"
....
Nice Vigo, coming together now, slowly but surely:)
Exactly.....time for that 8k !!!!
I remember annual list was due until october 2011...
they've anticipated that...
mmmm.....
if we'll see an 8k/news, watch out the fireworks...
With each passing week it seems like things are falling into place as to something positive about to happen. BTW, sent an e-mail to Mr Sapte the other day....no response to date.
Found this about RAM NIMMAGUDDA:
http://www.cancer-health.info/spherix-incorporated-appoints-dr-ram-nimmagudda-as-director-of-new-business-development/
BETHESDA, Md., Sept 10 Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology, and pharmaceutical companies, today announced that, effective August 31, 2009, Ram R. Nimmagudda, Ph.D., has joined the company as Director of New Business Development.
Dr. Nimmagudda brings to Spherix more than ? years of years of experience in business development, nutrition and nutraceutical industries, with particular expertise in novel food ingredients. At Spherix, Dr. Nimmagudda will be responsible for developing new business opportunities for both of Spherix’s wholly-owned subsidiaries – Spherix Consulting and Biospherics.
Dr. Nimmagudda has extensive experience in research, regulatory processes, operations, supply chain management, and business development. Most recently, Dr. Nimmagudda held the position of Director of New Business Development, South Asia for DSM Functional Foods where he oversaw the strategic development and execution of the company’s functional foods business plan for the region. In this role, he focused on initiating market development activities that supported the regional growth of DSM’s functional food product business in South Asia, and participating in the due diligence activities of local acquisitions and subsequent integration teams.
“Ram’s expertise in taking technologies from discovery to commercialization in global settings, coordinating international project teams, and directing the identification, acquisition, and development of health oriented and bioactive ingredients will be a valuable resource for all of us at Spherix,” said Dr. Claire Kruger, Chief Executive Officer of Spherix. “Ram is an ideal fit for Spherix, as he has overseen regulatory programs, patent processes, technology scouting, and clinical research; and has vast knowledge in implementing consumer insights, testing concepts, and conducting market analyses. Ram’s extensive experience in directing growth activities will be a tremendous asset as D-tagatose makes its way through the FDA approval process toward commercialization and as Spherix Consulting continues to grow in its scope and product offerings.”
Prior to his time at DSM, Dr. Nimmagudda held the position of Director and Sr. Principal Technologist, External Technologies at Wm. Wrigley Jr. Co., where he led the Company’s technology scouting and innovation programs and initiated joint development agreements with CALTECH, MIT, and other strategic industrial research companies. Before joining Wrigley, Dr. Nimmagudda served as Vice President of Technology Growth at Chr. Hansen, Inc. where he successfully initiated a growth program focused on capturing new technologies and developing novel commercialization processes to bring products to market. He also directed technology and market analysis on potential developments in the fields of medical nutrition, infant nutrition, nutraceuticals, probiotics, and bioactive proteins and peptide compounds, primarily relating to cardiovascular, gastrointestinal, oral health, and women’s health. Additionally, he has developed partnerships with universities and companies to research and obtain compounds with commercial promise. Dr. Nimmagudda received his Ph.D. in Biochemistry from Mangalore University, India; his M.S. in Biochemistry from Mysore University, India; and his B.S. in Chemistry and Biology from Osmania University, India.
.....
RAM NIMMAGUDDA new secretary & treasurer:
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=8qEbev8c46vcnLp8Mf%252brbw%253d%253d
....
SOS NEVADA update!
08/18/2011 ANNUAL LIST:
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=8qEbev8c46vcnLp8Mf%252brbw%253d%253d&CorpName=SYNOVICS+PHARMACEUTICALS%2c+INC.
....
yw, thanks to you.
I see said the blind man... Thanks for the words of wisdom
I will monitor EXTREMELY closely
Thanks, buddy. Of course, nothing is sure until we'll see a filing/news. But there are some positive clues...
hahahaha You are right though
...With a news/filing about a RM and with this super low float, you have to pray to grab some shares...
I like you
No prayers here, i do my own DD.
Do the same, man.
With a news/filing about a RM and with this super low float, you have to pray to grab some shares...
Good luck!
Other then the potential reverse merger with maneesh, SYVC has nothing going for it.
Is it worth buying a few shares and praying for positive developments? maybe... but I wouldn't bet the farm on it.
At this stage, this stock is not worth considering. I would rather pay 0.25 IF a reverse merger ever happens then pay 0.05 and pray for something to happen.
The trading is dead and it's very illiquid. If I wanted to buy shares, I will most likely have to hit the ask all the time, and since there aren't many buyers out there, MMs can play with the bid and ask as they please. They will drop the price with 100 shares like they did yesterday.
This is obviously my opinion only.
Do your own DD, of course!
SYVC was on the Undiscovered Gemz - Mid to Long Holds chat board.
I will do some DD on this comapny. If no reverse merger happens, then this stock is not going anywhere. It is very risky.
Good luck and IMO
http://sunbiz.org/pdf/09851855.pdf
It was filed with SOS of florida about 20 days ago:
Kirk is one of the former subsidiaries of SYVC...
Take @ look at the contact person and HIS EMAIL!....
They are cleaning the shell before the big reverse merger, if you ask me....
Don't recall the move, what did they do?
Patience game... Also vfin movement on friday was strange... uhm...
Will they ever do something? Strange move to .09 !!!
hope to see new dips, so i can load more shares....
Sooner rather then later......would be a really good thing !!!!
waiting for the real jackpot: 8-k....
.....
Just noticed that. Would be nice to see it printed.
Strange to see MMs @ $5 on a shell....
Something big on the way, bro...
Glad to hold shares of this baby...
.....
agree bro, .0996 up and ask looking THIN
Something is up, look @ L2....
Certainly is and could we be close to hearing what the plan might be ? Hope so !!!!!
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
244
|
Created
|
10/20/08
|
Type
|
Free
|
Moderators |
SYVC - Synovics Pharmaceuticals, Inc. (Nevada corporation)
Ticker: SYVC (PINKSHEETS NO INFORMATION) - 15-12G FILED WITH THE SEC ON DEC. 11, 2009
COMPANY INFO ON PINKSHEETS: http://www.otcmarkets.com/stock/SYVC/company-infoFILINGS ON PINKSHEETS: http://www.otcmarkets.com/stock/SYVC/financials
SYVC on NEVADA Secretary of State: http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=8qEbev8c46vcnLp8Mf%252brbw%253d%253d
Synovics Pharmaceuticals, Inc.
5360 Northwest 35th Avenue
Fort Lauderdale, FL 33309
Phone: 954-486-4590
SYVC
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |